CABALETTA BIO INC's ticker is CABA and the CUSIP is 12674W109. A total of 65 filers reported holding CABALETTA BIO INC in Q4 2021. The put-call ratio across all filers is 0.31 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q4 2022 | $1,530,746 | +346.3% | 165,486 | -68.6% | 0.24% | +226.4% |
| Q3 2022 | $343,000 | -40.9% | 527,805 | -3.5% | 0.07% | -51.4% |
| Q2 2022 | $580,000 | -53.6% | 546,800 | -11.3% | 0.15% | -63.5% |
| Q1 2022 | $1,251,000 | -48.8% | 616,125 | -4.4% | 0.41% | -68.9% |
| Q4 2021 | $2,443,000 | – | 644,583 | – | 1.31% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Lynx1 Capital Management LP | 2,825,976 | $26,140,278 | 22.61% |
| VR Adviser, LLC | 1,895,285 | $17,531,386 | 2.95% |
| CAXTON CORP | 84,728 | $783,735 | 2.00% |
| COMMODORE CAPITAL LP | 1,010,359 | $9,346 | 1.41% |
| BOONE CAPITAL MANAGEMENT LLC | 266,882 | $2,468,659 | 1.27% |
| Cormorant Asset Management, LP | 1,971,739 | $18,239 | 1.22% |
| TCG Crossover Management, LLC | 486,795 | $4,502,854 | 0.80% |
| Boxer Capital, LLC | 540,000 | $4,995,000 | 0.26% |
| Kynam Capital Management, LP | 165,486 | $1,530,746 | 0.24% |
| Eversept Partners, LP | 282,874 | $2,616,585 | 0.23% |